LQDA - Liquidia Corporation

Analysis of Liquidia Corporation(LQDA), Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes variou

Liquidia Corporation

LQDA

NASDAQ

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

12.53 USD

0.16 (1.28%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Upgrades & Downgrades

We are unable to load this data!

Price PriceTargets

We are unable to load the data!

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.